Plasma Concentrations of Benzylpenicillin and Cloxacillin in Infective Endocarditis—With Special Reference to Delayed Hypersensitivity Reactions

Background: Current antibiotic regimens for infective endocarditis (IE) are effective but pose a high risk of delayed hypersensitivity reactions (DHR). Dose adjustments guided by therapeutic drug monitoring (TDM) could mitigate these risks while maintaining treatment efficacy. This study aimed to in...

Full description

Saved in:
Bibliographic Details
Main Authors: Malin Hägglund, Ulrika Snygg-Martin, Lars Olaison, Michael Stofkoper, Bert Ove Larsson, Magnus Brink
Format: Article
Language:English
Published: MDPI AG 2025-01-01
Series:Antibiotics
Subjects:
Online Access:https://www.mdpi.com/2079-6382/14/1/56
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832589321050259456
author Malin Hägglund
Ulrika Snygg-Martin
Lars Olaison
Michael Stofkoper
Bert Ove Larsson
Magnus Brink
author_facet Malin Hägglund
Ulrika Snygg-Martin
Lars Olaison
Michael Stofkoper
Bert Ove Larsson
Magnus Brink
author_sort Malin Hägglund
collection DOAJ
description Background: Current antibiotic regimens for infective endocarditis (IE) are effective but pose a high risk of delayed hypersensitivity reactions (DHR). Dose adjustments guided by therapeutic drug monitoring (TDM) could mitigate these risks while maintaining treatment efficacy. This study aimed to investigate the plasma concentration of benzylpenicillin and cloxacillin in patients with IE and explore associations between antibiotic concentrations and DHR. Methods: Plasma concentrations of benzylpenicillin and cloxacillin were measured as centre (midpoint concentrations between consecutive doses) and trough values during the first and third weeks of treatment in patients with IE. Patient characteristics and outcomes, including DHR, were documented. Results: A total of 55 patients were included, with 37 patients (67%) receiving benzylpenicillin and 18 (33%) receiving cloxacillin. The 90-day mortality rate was 3%. Both centre and trough concentration exhibited substantial interpatient variation for the two antibiotics, while intra-patient variability between weeks 1 and 3 remained low for most patients. Kidney function could explain, at best, 54% of the variation, and a multiple regression model including kidney function, body mass index, age, and albumin explained up to 68% of the variation for benzylpenicillin. There was no relation between high plasma concentration and the prevalence of DHR; conversely, we observed a tendency of low plasma concentrations in these patients. Conclusions: This study revealed significant interindividual variation in plasma concentrations for both studied penicillins. TDM might be useful in situations where concentrations are hard to predict, such as severe obesity or kidney failure. Additionally, we found no indication that high plasma concentrations are related to the prevalence of DHR.
format Article
id doaj-art-462e3581b9d44dc68da9824a685f8112
institution Kabale University
issn 2079-6382
language English
publishDate 2025-01-01
publisher MDPI AG
record_format Article
series Antibiotics
spelling doaj-art-462e3581b9d44dc68da9824a685f81122025-01-24T13:18:46ZengMDPI AGAntibiotics2079-63822025-01-011415610.3390/antibiotics14010056Plasma Concentrations of Benzylpenicillin and Cloxacillin in Infective Endocarditis—With Special Reference to Delayed Hypersensitivity ReactionsMalin Hägglund0Ulrika Snygg-Martin1Lars Olaison2Michael Stofkoper3Bert Ove Larsson4Magnus Brink5Department of Infectious Diseases, Sahlgrenska University Hospital, Region Västra Götaland, Diagnosvägen 21, SE-41650 Gothenburg, SwedenDepartment of Infectious Diseases, Sahlgrenska University Hospital, Region Västra Götaland, Diagnosvägen 21, SE-41650 Gothenburg, SwedenDepartment of Infectious Diseases, Sahlgrenska University Hospital, Region Västra Götaland, Diagnosvägen 21, SE-41650 Gothenburg, SwedenDepartment of Infectious Diseases, Södra Älvsborgs Sjukhus, Region Västra Götaland, Samaritvägen 1, SE-50740 Borås, SwedenDepartment of Infectious Diseases, Norra Älvsborgs Länssjukhus, Regions Västra Götaland, Lärketorpsvägen 20, SE-46173 Trollhättan, SwedenDepartment of Infectious Diseases, Sahlgrenska University Hospital, Region Västra Götaland, Diagnosvägen 21, SE-41650 Gothenburg, SwedenBackground: Current antibiotic regimens for infective endocarditis (IE) are effective but pose a high risk of delayed hypersensitivity reactions (DHR). Dose adjustments guided by therapeutic drug monitoring (TDM) could mitigate these risks while maintaining treatment efficacy. This study aimed to investigate the plasma concentration of benzylpenicillin and cloxacillin in patients with IE and explore associations between antibiotic concentrations and DHR. Methods: Plasma concentrations of benzylpenicillin and cloxacillin were measured as centre (midpoint concentrations between consecutive doses) and trough values during the first and third weeks of treatment in patients with IE. Patient characteristics and outcomes, including DHR, were documented. Results: A total of 55 patients were included, with 37 patients (67%) receiving benzylpenicillin and 18 (33%) receiving cloxacillin. The 90-day mortality rate was 3%. Both centre and trough concentration exhibited substantial interpatient variation for the two antibiotics, while intra-patient variability between weeks 1 and 3 remained low for most patients. Kidney function could explain, at best, 54% of the variation, and a multiple regression model including kidney function, body mass index, age, and albumin explained up to 68% of the variation for benzylpenicillin. There was no relation between high plasma concentration and the prevalence of DHR; conversely, we observed a tendency of low plasma concentrations in these patients. Conclusions: This study revealed significant interindividual variation in plasma concentrations for both studied penicillins. TDM might be useful in situations where concentrations are hard to predict, such as severe obesity or kidney failure. Additionally, we found no indication that high plasma concentrations are related to the prevalence of DHR.https://www.mdpi.com/2079-6382/14/1/56therapeutic drugmonitoringinfective endocarditisbeta-lactamsdelayed hypersensitivity reactionbeta-lactam fever
spellingShingle Malin Hägglund
Ulrika Snygg-Martin
Lars Olaison
Michael Stofkoper
Bert Ove Larsson
Magnus Brink
Plasma Concentrations of Benzylpenicillin and Cloxacillin in Infective Endocarditis—With Special Reference to Delayed Hypersensitivity Reactions
Antibiotics
therapeutic drug
monitoring
infective endocarditis
beta-lactams
delayed hypersensitivity reaction
beta-lactam fever
title Plasma Concentrations of Benzylpenicillin and Cloxacillin in Infective Endocarditis—With Special Reference to Delayed Hypersensitivity Reactions
title_full Plasma Concentrations of Benzylpenicillin and Cloxacillin in Infective Endocarditis—With Special Reference to Delayed Hypersensitivity Reactions
title_fullStr Plasma Concentrations of Benzylpenicillin and Cloxacillin in Infective Endocarditis—With Special Reference to Delayed Hypersensitivity Reactions
title_full_unstemmed Plasma Concentrations of Benzylpenicillin and Cloxacillin in Infective Endocarditis—With Special Reference to Delayed Hypersensitivity Reactions
title_short Plasma Concentrations of Benzylpenicillin and Cloxacillin in Infective Endocarditis—With Special Reference to Delayed Hypersensitivity Reactions
title_sort plasma concentrations of benzylpenicillin and cloxacillin in infective endocarditis with special reference to delayed hypersensitivity reactions
topic therapeutic drug
monitoring
infective endocarditis
beta-lactams
delayed hypersensitivity reaction
beta-lactam fever
url https://www.mdpi.com/2079-6382/14/1/56
work_keys_str_mv AT malinhagglund plasmaconcentrationsofbenzylpenicillinandcloxacillinininfectiveendocarditiswithspecialreferencetodelayedhypersensitivityreactions
AT ulrikasnyggmartin plasmaconcentrationsofbenzylpenicillinandcloxacillinininfectiveendocarditiswithspecialreferencetodelayedhypersensitivityreactions
AT larsolaison plasmaconcentrationsofbenzylpenicillinandcloxacillinininfectiveendocarditiswithspecialreferencetodelayedhypersensitivityreactions
AT michaelstofkoper plasmaconcentrationsofbenzylpenicillinandcloxacillinininfectiveendocarditiswithspecialreferencetodelayedhypersensitivityreactions
AT bertovelarsson plasmaconcentrationsofbenzylpenicillinandcloxacillinininfectiveendocarditiswithspecialreferencetodelayedhypersensitivityreactions
AT magnusbrink plasmaconcentrationsofbenzylpenicillinandcloxacillinininfectiveendocarditiswithspecialreferencetodelayedhypersensitivityreactions